AZD8683 Multiple Dose Study in Healthy Volunteers and Chronic Obstructive Pulmonary Disease (COPD) Patients

PHASE1TerminatedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
COPD
Interventions
DRUG

AZD8683

Multiple dose, oral inhalation (Healthy volunteers) Multiple dose, oral inhalation (COPD patients)

DRUG

Placebo

Multiple dose, oral inhalation (Healthy volunteers) Multiple dose, oral inhalation (COPD patients

Trial Locations (1)

Unknown

London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY